MAKING SCIENCE GROUP SA (ALMKS.PA) Fundamental Analysis & Valuation

EPA:ALMKS • ES0105463006

Current stock price

7.9 EUR
0 (0%)
Last:

This ALMKS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALMKS.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALMKS has reported negative net income.
  • ALMKS had a positive operating cash flow in the past year.
  • In the past 5 years ALMKS reported 4 times negative net income.
  • ALMKS had a positive operating cash flow in 4 of the past 5 years.
ALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -0.94%, ALMKS is doing worse than 62.12% of the companies in the same industry.
  • ALMKS's Return On Equity of -4.48% is on the low side compared to the rest of the industry. ALMKS is outperformed by 62.12% of its industry peers.
  • The Return On Invested Capital of ALMKS (7.00%) is better than 68.18% of its industry peers.
  • ALMKS had an Average Return On Invested Capital over the past 3 years of 2.93%. This is below the industry average of 7.74%.
  • The last Return On Invested Capital (7.00%) for ALMKS is above the 3 year average (2.93%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROIC 7%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ALMKS.PA Yearly ROA, ROE, ROICALMKS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 50 100 150

1.3 Margins

  • ALMKS's Profit Margin has improved in the last couple of years.
  • ALMKS has a Operating Margin (1.87%) which is in line with its industry peers.
  • ALMKS's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 20.58%, ALMKS is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
  • ALMKS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.87%
PM (TTM) N/A
GM 20.58%
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
ALMKS.PA Yearly Profit, Operating, Gross MarginsALMKS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALMKS.PA Health Analysis

2.1 Basic Checks

  • ALMKS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ALMKS has more shares outstanding
  • ALMKS has more shares outstanding than it did 5 years ago.
  • ALMKS has a better debt/assets ratio than last year.
ALMKS.PA Yearly Shares OutstandingALMKS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
ALMKS.PA Yearly Total Debt VS Total AssetsALMKS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

  • ALMKS has an Altman-Z score of 1.79. This is a bad value and indicates that ALMKS is not financially healthy and even has some risk of bankruptcy.
  • With a decent Altman-Z score value of 1.79, ALMKS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • The Debt to FCF ratio of ALMKS is 1.06, which is an excellent value as it means it would take ALMKS, only 1.06 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.06, ALMKS belongs to the top of the industry, outperforming 87.88% of the companies in the same industry.
  • ALMKS has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
  • ALMKS has a better Debt to Equity ratio (0.21) than 71.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Altman-Z 1.79
ROIC/WACC1.03
WACC6.83%
ALMKS.PA Yearly LT Debt VS Equity VS FCFALMKS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 0.84 indicates that ALMKS may have some problems paying its short term obligations.
  • The Current ratio of ALMKS (0.84) is worse than 60.61% of its industry peers.
  • ALMKS has a Quick Ratio of 0.84. This is a bad value and indicates that ALMKS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of ALMKS (0.82) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.82
ALMKS.PA Yearly Current Assets VS Current LiabilitesALMKS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ALMKS.PA Growth Analysis

3.1 Past

  • ALMKS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 62.80%, which is quite impressive.
  • Measured over the past years, ALMKS shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.14% on average per year.
  • The Revenue has grown by 16.02% in the past year. This is quite good.
  • ALMKS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.27% yearly.
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%

3.2 Future

  • Based on estimates for the next years, ALMKS will show a very negative growth in Earnings Per Share. The EPS will decrease by -63.53% on average per year.
  • The Revenue is expected to grow by 16.23% on average over the next years. This is quite good.
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ALMKS.PA Yearly Revenue VS EstimatesALMKS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ALMKS.PA Yearly EPS VS EstimatesALMKS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALMKS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALMKS. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 70.41, ALMKS can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, ALMKS is valued a bit more expensive than 60.61% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 38.51. ALMKS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 70.41
ALMKS.PA Price Earnings VS Forward Price EarningsALMKS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60

4.2 Price Multiples

  • ALMKS's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, ALMKS is valued cheaply inside the industry as 98.48% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.87
EV/EBITDA 5.78
ALMKS.PA Per share dataALMKS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • A cheap valuation may be justified as ALMKS's earnings are expected to decrease with -63.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.53%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ALMKS.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.32%, ALMKS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 3.40, ALMKS has a dividend in line with its industry peers.
  • ALMKS's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALMKS.PA Yearly Dividends per shareALMKS.PA Yearly Dividends per shareYearly Dividends per share 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y-63.53%
EPS Next 3YN/A
ALMKS.PA Yearly Income VS Free CF VS DividendALMKS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALMKS.PA Fundamentals: All Metrics, Ratios and Statistics

MAKING SCIENCE GROUP SA

EPA:ALMKS (4/17/2026, 7:00:00 PM)

7.9

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-19
Earnings (Next)N/A
Inst Owners4.21%
Inst Owner ChangeN/A
Ins Owners58.8%
Ins Owner ChangeN/A
Market Cap71.81M
Revenue(TTM)273.54M
Net Income(TTM)-1.72M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-70.27%
EPS NY rev (3m)-73.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.41
P/S 0.26
P/FCF 1.87
P/OCF 1.86
P/B 1.87
P/tB N/A
EV/EBITDA 5.78
EPS(TTM)-0.19
EYN/A
EPS(NY)0.11
Fwd EY1.42%
FCF(TTM)4.22
FCFY53.44%
OCF(TTM)4.24
OCFY53.68%
SpS30.09
BVpS4.22
TBVpS-2.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.94%
ROE -4.48%
ROCE 9.53%
ROIC 7%
ROICexc 19.52%
ROICexgc N/A
OM 1.87%
PM (TTM) N/A
GM 20.58%
FCFM 14.03%
ROA(3y)3.28%
ROA(5y)0.56%
ROE(3y)10.53%
ROE(5y)-7.2%
ROIC(3y)2.93%
ROIC(5y)N/A
ROICexc(3y)5.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.1%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-58.8%
PM growth 3YN/A
PM growth 5Y22.36%
GM growth 3Y-12.18%
GM growth 5Y-12.78%
F-Score6
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.06
Debt/EBITDA 0.63
Cap/Depr 2.28%
Cap/Sales 0.06%
Interest Coverage 1.19
Cash Conversion 304.51%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.82
Altman-Z 1.79
F-Score6
WACC6.83%
ROIC/WACC1.03
Cap/Depr(3y)8.61%
Cap/Depr(5y)162.22%
Cap/Sales(3y)0.2%
Cap/Sales(5y)5.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.8%
EPS 3YN/A
EPS 5Y64.14%
EPS Q2Q%-315.38%
EPS Next Y-94.15%
EPS Next 2Y-63.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.02%
Revenue growth 3Y18.35%
Revenue growth 5Y43.27%
Sales Q2Q%21.07%
Revenue Next Year18.37%
Revenue Next 2Y16.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y279.09%
EBIT growth 3YN/A
EBIT growth 5Y-40.98%
EBIT Next Year83.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76352.4%
FCF growth 3Y58.75%
FCF growth 5YN/A
OCF growth 1Y11729.2%
OCF growth 3Y52.22%
OCF growth 5Y61.77%

MAKING SCIENCE GROUP SA / ALMKS.PA Fundamental Analysis FAQ

What is the fundamental rating for ALMKS stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALMKS.PA.


Can you provide the valuation status for MAKING SCIENCE GROUP SA?

ChartMill assigns a valuation rating of 2 / 10 to MAKING SCIENCE GROUP SA (ALMKS.PA). This can be considered as Overvalued.


How profitable is MAKING SCIENCE GROUP SA (ALMKS.PA) stock?

MAKING SCIENCE GROUP SA (ALMKS.PA) has a profitability rating of 3 / 10.